Fleroxacin
Spécifications
79660-72-3Numéro CAS
677-525-2Numéro CE
6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acidNom IUPAC
C17H18F3N3O3Formule chimique
369.34 g/molMasse molaire
fleroxacin; 79660-72-3; Megalone; Megalocin; Fleroxicin; Fleroxacino; Quinodis; Fleroxacine; Fleroxacinum; AM-833; AM 833; FLRX; Ro 23-6240/000; DTXSID1046714; Ro-236240; 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid; CHEBI:31810; Ro-23-6240/000; N804LDH51K; Ro-236240000; 3-Quinolinecarboxylic acid, 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-; DTXCID9026714; Ro 236240; Ro 23 6240; RefChem:388981; J01MA08; 677-525-2; AM833; 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid; Ro 23-6240; 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; MFCD00864880; Fleroxacin (Quinodis); 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid; NCGC00167558-01; Fleroxacine [French]; Fleroxacinum [Latin]; Fleroxacino [Spanish]; RO 23-6240;AM-833; Megalosin; Megalocin (TN); Megalone (TN); SMR000466302; CAS-79660-72-3; CCRIS 3972; SR-01000759379; BRN 4300996; UNII-N804LDH51K; Fleroxacin (JAN/USAN/INN); Fleroxacin [USAN:INN:BAN:JAN]; 6,8-Difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-quinolinecarboxylic acid; FLEROXACIN [MI]; FLEROXACIN [INN]; FLEROXACIN [JAN]; 79660-53-0; FLEROXACIN [USAN]; F0646; Epitope ID:540292; FLEROXACIN [MART.]; CHEMBL6273; FLEROXACIN [WHO-DD]; SCHEMBL48145; MLS000759401; MLS006010715; orb1221579; orb1309083; orb3025543; SCHEMBL29377022; GTPL12476; MSK5719; HMS2090I08; HMS3715B11; MSK5719-100DM; HY-B0414; RKL10075; MSK5719-1000DM; Tox21_112553; BDBM50247892; MSK5719-100D; MSK5719-100M; s2469; ZINC03786299; AKOS015907011; MSK5719-1000D; Tox21_112553_1; AF23303; CCG-221125; DB04576; KS-5124; Fleroxacin Solution in DMSO, 100ug/mL; NCGC00167558-02; 3-Quinolinecarboxylic acid, 1,4-dihydro-6,8-difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-; SY057457; Fleroxacin Solution in DMSO, 1000ug/mL; Fleroxacin Solution in Methanol, 100ug/mL; F4518; NS00005485; D01716; Fleroxacin, VETRANAL(TM), analytical standard; AB00640001-02; AB00640001-03; AB00640001_04; Fleroxacin Solution in DMSO/Methanol, 100ug/mL; F858783; Fleroxacin Solution in DMSO/Methanol, 1000ug/mL; Q3746573; SR-01000759379-2; SR-01000759379-3; BRD-K61717546-001-04-3; BRD-K61717546-001-05-0; 6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid-; 6,8-Difluoro-1-(2-fluoroethyl)-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid; 6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacidSynonymes
